InfuSystem Holdings (INFU) Stock Analysis & Winston Score
InfuSystem Holdings is a healthcare company that provides infusion therapy services and equipment across the United States. It rents and manages infusion pumps — devices that deliver medicine, like chemotherapy drugs, directly into a patient's body at a controlled rate. Its main customers are hospitals, oncology clinics, and other healthcare providers who need these pumps without buying and maintaining them outright. The company makes money primarily by renting infusion pumps and providing related services, including pump management, repair, and logistics support. It operates entirely within the U.S. and generates around $120–130 million in annual revenue. Its competitive position comes from being one of the few scaled, specialized pump rental networks in the country, which makes it difficult for smaller competitors to match its service coverage. The key growth driver is expanding its oncology and pain management pump programs, but the main risk is customer concentration and reimbursement pressure from insurers and Medicare, which could squeeze margins over time.
Winston Score: 62/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Mixed (11/30)
- Growth: Exceptional (17/20)
- Cash Flow: Exceptional (9/10)
- Stability: Exceptional (9/10)
- Valuation: Good (5/10)
- Ownership: Good (8/15)
Key Facts
Price: $8.92
Market Cap: $180M
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: New York Stock Exchange American


